Reduced Competition Adds $35 to Regeneron (REGN) DCF, Deutsche Bank Raises PT to $310
Tweet Send to a Friend
Deutsche Bank today maintained a Buy rating on Regeneron Pharma (NASDAQ: REGN) and raised its price target to $310.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
